Abstract:As a result of thrombosis or intimal hyperplasia, synthetic artificial vascular grafts had a low success rate when they were used to replace small-diameter arteries (inner diameter < 6 mm). C-type natriuretic peptides (CNP) have anti-thrombotic effects, and can promote endothelial cell (EC) proliferation and in-hibit vascular smooth muscle cell (SMC) over-growth. In this study, poly(epsilon-caprolactone) (PCL) vascular grafts loaded with CNP (PCL-CNP) were constructed by electrospinning. The PCL-CNP grafts were able to continuously release CNP at least 25 days in vitro . The results of scanning electron microscopy (SEM) and mechanical testing showed that the loading of CNP did not change the microstructure and mechani-cal properties of the PCL grafts. In vitro blood compatibility analysis displayed that PCL-CNP grafts could inhibit thrombin activity and reduce platelet adhesion and activation. In vitro cell experiments demon-strated that PCL-CNP grafts activated ERK1/2 and Akt signaling in human umbilical vein endothelial cells (HUVECs), as well as increased cyclin D1 expression, enhanced proliferation and migration, and increased vascular endothelial growth factor (VEGF) secretion and nitric oxide (NO) production. The rabbit arteri-ovenous (AV)-shunt ex vitro indicated that CNP loading significantly improved the antithrombogenicity of PCL grafts. The assessment of vascular grafts in rat abdominal aorta implantation model displayed that PCL-CNP grafts promoted the regeneration of ECs and contractile SMCs, modulated macrophage polariza-tion toward M2 phenotype, and enhanced extracellular matrix remodeling. These findings confirmed for the first time that loading CNP is an effective approach to improve the hemocompatibility and vascular regeneration of synthetic vascular grafts.Statement of significanceSmall-diameter (< 6 mm) vascular grafts (SDVGs) have not been made clinically available due to their prevalence of thrombosis, limited endothelial regeneration and intimal hyperplasia. The incorporation of bioactive molecules into SDVGs serves as an effective solution to improve hemocompatibility and en-dothelialization. In this study, for the first time, we loaded C-type natriuretic peptides (CNP) into PCL grafts by electrospunning and confirmed the effectiveness of loading CNP on improving the hemocompat-ibility and vascular regeneration of artificial vascular grafts. Regenerative advantages included enhance-ment of endothelialization, modulation of macrophage polarization toward M2 phenotypes, and improved contractile smooth muscle cell regeneration. Our investigation brings attention to CNP as a valuable bioac-tive molecule for modifying cardiovascular biomaterial.(c) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

The loading of C-type natriuretic peptides improved hemocompatibility and vascular regeneration of electrospun poly(-caprolactone) grafts

Nitrate-Functionalized poly(ε-Caprolactone) Small-Diameter Vascular Grafts Enhance Vascular Regeneration via Sustained Release of Nitric Oxide

Nitrate-Functionalized poly(-Caprolactone) Small-Diameter Vascular Grafts Enhance Vascular Regeneration <i>via</i> Sustained Release of Nitric Oxide

Biofunctionalized Electrospun PCL-PIBMD/SF Vascular Grafts with PEG and Cell-Adhesive Peptides for Endothelialization

Functional Modification of Electrospun Poly(ε-caprolactone) Vascular Grafts with the Fusion Protein VEGF–HGFI Enhanced Vascular Regeneration

Endothelialization and Patency of Rgd-Functionalized Vascular Grafts in A Rabbit Carotid Artery Model

Enhanced Cellular Function of Human Vascular Endothelial Cell on Poly (Ε-Caprolactone)/gelatin Coaxial-Electrospun Scaffold

Improving Vascular Regeneration Performance of Electrospun Poly(ε-Caprolactone) Vascular Grafts via Synergistic Functionalization with VE-Cadherin/VEGF

Rapid Endothelialization and Controlled Smooth Muscle Regeneration by Electrospun Heparin-Loaded Polycaprolactone/gelatin Hybrid Vascular Grafts

Hybrid Small-Diameter Vascular Grafts: Anti-expansion Effect of Electrospun Poly Ε-Caprolactone on Heparin-Coated Decellularized Matrices

Nitric Oxide-Releasing Poly(ε-Caprolactone)/s-nitrosylated Keratin Biocomposite Scaffolds for Potential Small-Diameter Vascular Grafts.

Coaxially-structured fibres with tailored material properties for vascular graft implant

Remodeling of Structurally Reinforced (Tpu+pcl/pcl)-Hep Electrospun Small-Diameter Bilayer Vascular Grafts Interposed in Rat Abdominal Aortas.

Anticoagulant Hydrogel Tubes with Poly(ɛ‐Caprolactone) Sheaths for Small‐Diameter Vascular Grafts

The Effect of Thick Fibers and Large Pores of Electrospun Poly(ε-Caprolactone) Vascular Grafts on Macrophage Polarization and Arterial Regeneration.

Appropriate density of PCL nano-fiber sheath promoted muscular remodeling of PGS/PCL grafts in arterial circulation

Gelatin Coating Promotes In Situ Endothelialization Of Electrospun Polycaprolactone Vascular Grafts

Direct thrombin inhibitor-bivalirudin improved the hemocompatibility of electrospun polycaprolactone vascular grafts

Co-immobilization of ACH11 Antithrombotic Peptide and CAG Cell-Adhesive Peptide Onto Vascular Grafts for Improved Hemocompatibility and Endothelialization.

Development of a Decellularized Human Amniotic Membrane-Based Electrospun Vascular Graft Capable of Rapid Remodeling for Small-Diameter Vascular Applications.

Electrospun Polycaprolactone/collagen Nanofibers Cross-Linked with 1-Ethyl-3-(3-dimethylaminopropyl) Carbodiimide/n-Hydroxysuccinimide and Genipin Facilitate Endothelial Cell Regeneration and May Be a Promising Candidate for Vascular Scaffolds.